Details checkedStrong evidenceCheckedpublication

ONWARD ARC-BCI / DigitalBridge

Also known as: ARC-BCI, ONWARD DigitalBridge, WIMAGINE BCI, ARC-IM BCI bridge

ONWARD Medical

Primary source

Company

ONWARD Medical

Program Type

Software/Neurotech

Modality

BCI/Neurotech

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Implanted cortical BCI linked to ARC-IM stimulation and external AI decoding software

Confidence

88%

Status Confidence

Status confirmed

Evidence Strength

Strong evidence

Last Reviewed

2026-06-10

Geography

United States, Europe

Population

adult, implantable-bci, neurorestoration, assistive-technology, investigational-device, motor-intent-decoding

Trial IDs

Mechanism

Implanted brain-computer interface and AI decoding workflow that interprets movement intentions from brain signals and links them to ARC-IM spinal-cord stimulation, forming ONWARD's DigitalBridge neurorestoration platform.

Indications

Severe Paralysis Communication Impairment

Notes

Motor-neurorestoration BCI record rather than a hearing-loss treatment. Included because ARC-BCI/DigitalBridge is a prominent implanted neurotechnology platform using neural decoding and closed-loop assistive output, adjacent to communication and accessibility BCI taxonomy.

Evidence & Sources

2 structured sources

company

Supports: canonicalName, aliases, company, mechanism, status, route, populationTags, keyEvents

Open

publication

Supports: mechanism, stage, keyEvents

Open

Key Events

2023-05-24

Nature published first-in-human DigitalBridge results linking brain intent decoding to spinal-cord stimulation for walking after paralysis

2024-01-01